https://www.bloomberg.com/authors/AWqyjzjPWLQ/ashleigh-furlonghttps://www.bloomberg.com/feeds/static/images/bloomberg_logo_black.pnghttps://www.bloomberg.com/authors/AWqyjzjPWLQ/ashleigh-furlongRSS for NodeFri, 29 Aug 2025 13:04:55 GMThttps://www.bloomberg.com/news/articles/2025-08-22/breakdown-in-uk-drug-pricing-talks-threatens-pharma-investmenthttps://www.bloomberg.com/news/articles/2025-08-22/breakdown-in-uk-drug-pricing-talks-threatens-pharma-investmentFri, 22 Aug 2025 11:13:17 GMTMedication at an NHS hospital in the UK. Photographer: Andy Buchanan/WPA/Getty Imageshttps://www.bloomberg.com/news/articles/2025-08-21/novo-nordisk-s-wegovy-sees-uk-demand-boosted-by-mounjaro-price-risehttps://www.bloomberg.com/news/articles/2025-08-21/novo-nordisk-s-wegovy-sees-uk-demand-boosted-by-mounjaro-price-riseThu, 21 Aug 2025 08:00:00 GMTNovo Nordisk’s Wegovy injection penshttps://www.bloomberg.com/news/articles/2025-08-14/lilly-hikes-uk-obesity-shot-price-as-trump-pressures-drugmakershttps://www.bloomberg.com/news/articles/2025-08-14/lilly-hikes-uk-obesity-shot-price-as-trump-pressures-drugmakersThu, 14 Aug 2025 13:11:37 GMTEli Lilly & Co. Mounjaro medicationhttps://www.bloomberg.com/news/articles/2025-08-13/adhd-medicines-reduce-suicide-crime-risks-in-sweeping-studyhttps://www.bloomberg.com/news/articles/2025-08-13/adhd-medicines-reduce-suicide-crime-risks-in-sweeping-studyWed, 13 Aug 2025 22:30:00 GMThttps://www.bloomberg.com/news/newsletters/2025-08-08/preventing-a-fungal-pandemic-like-in-the-last-of-ushttps://www.bloomberg.com/news/newsletters/2025-08-08/preventing-a-fungal-pandemic-like-in-the-last-of-usFri, 08 Aug 2025 10:00:32 GMTCandida auris. Photographer: BSIP/Universal Images Group Editorialhttps://www.bloomberg.com/news/articles/2025-08-08/gsk-set-for-500-million-payment-from-mrna-lawsuit-settlementhttps://www.bloomberg.com/news/articles/2025-08-08/gsk-set-for-500-million-payment-from-mrna-lawsuit-settlementFri, 08 Aug 2025 07:27:07 GMThttps://www.bloomberg.com/news/articles/2025-08-05/smith-nephew-surges-on-500-million-buyback-plan-profit-beathttps://www.bloomberg.com/news/articles/2025-08-05/smith-nephew-surges-on-500-million-buyback-plan-profit-beatTue, 05 Aug 2025 07:33:16 GMTDeepak Nath Photographer: Jason Alden/Bloomberghttps://www.bloomberg.com/news/articles/2025-07-31/sanofi-profit-growth-slowed-by-spending-on-researchhttps://www.bloomberg.com/news/articles/2025-07-31/sanofi-profit-growth-slowed-by-spending-on-researchThu, 31 Jul 2025 05:30:00 GMThttps://www.bloomberg.com/news/articles/2025-07-30/gsk-s-profit-outshines-estimates-as-vaccines-keep-growinghttps://www.bloomberg.com/news/articles/2025-07-30/gsk-s-profit-outshines-estimates-as-vaccines-keep-growingWed, 30 Jul 2025 06:13:45 GMThttps://www.bloomberg.com/news/articles/2025-07-29/astrazeneca-weighs-direct-to-patient-drug-sales-in-ushttps://www.bloomberg.com/news/articles/2025-07-29/astrazeneca-weighs-direct-to-patient-drug-sales-in-usTue, 29 Jul 2025 13:03:29 GMThttps://www.bloomberg.com/news/articles/2025-07-29/astrazeneca-profit-revenue-lifted-by-cancer-drugshttps://www.bloomberg.com/news/articles/2025-07-29/astrazeneca-profit-revenue-lifted-by-cancer-drugsTue, 29 Jul 2025 06:09:28 GMThttps://www.bloomberg.com/news/articles/2025-07-25/lilly-gets-limited-european-backing-for-alzheimer-s-disease-drughttps://www.bloomberg.com/news/articles/2025-07-25/lilly-gets-limited-european-backing-for-alzheimer-s-disease-drugFri, 25 Jul 2025 10:55:36 GMTEli Lilly’s Kisunla drug. Source: Eli Lillyhttps://www.bloomberg.com/news/articles/2025-07-24/astrazeneca-says-its-automimmune-drug-reduced-disease-severityhttps://www.bloomberg.com/news/articles/2025-07-24/astrazeneca-says-its-automimmune-drug-reduced-disease-severityThu, 24 Jul 2025 06:34:04 GMThttps://www.bloomberg.com/news/articles/2025-07-22/sanofi-to-buy-vicebio-for-up-to-1-6-billion-in-respiratory-pushhttps://www.bloomberg.com/news/articles/2025-07-22/sanofi-to-buy-vicebio-for-up-to-1-6-billion-in-respiratory-pushTue, 22 Jul 2025 05:48:24 GMThttps://www.bloomberg.com/news/articles/2025-07-18/what-scientists-learned-scanning-the-bodies-of-100-000-britshttps://www.bloomberg.com/news/articles/2025-07-18/what-scientists-learned-scanning-the-bodies-of-100-000-britsFri, 18 Jul 2025 06:00:12 GMThttps://www.bloomberg.com/news/articles/2025-07-17/gsk-s-blood-cancer-drug-blenrep-fails-to-win-fda-panel-supporthttps://www.bloomberg.com/news/articles/2025-07-17/gsk-s-blood-cancer-drug-blenrep-fails-to-win-fda-panel-supportThu, 17 Jul 2025 17:02:57 GMTGSK headquarters in London.https://www.bloomberg.com/news/articles/2025-07-16/astrazeneca-rare-disease-drug-disappoints-in-late-stage-studyhttps://www.bloomberg.com/news/articles/2025-07-16/astrazeneca-rare-disease-drug-disappoints-in-late-stage-studyWed, 16 Jul 2025 06:46:57 GMThttps://www.bloomberg.com/news/articles/2025-07-14/astra-says-potential-blockbuster-reduced-high-blood-pressurehttps://www.bloomberg.com/news/articles/2025-07-14/astra-says-potential-blockbuster-reduced-high-blood-pressureMon, 14 Jul 2025 06:54:04 GMThttps://www.bloomberg.com/news/articles/2025-07-07/terry-smith-blasts-novo-coloplast-in-danish-life-science-rebukehttps://www.bloomberg.com/news/articles/2025-07-07/terry-smith-blasts-novo-coloplast-in-danish-life-science-rebukeMon, 07 Jul 2025 12:30:11 GMTTerry Smith Photographer: Stefan Rousseau/PA Images/Getty Imageshttps://www.bloomberg.com/news/articles/2025-07-03/eu-fight-against-trump-s-tariffs-is-blunted-by-corporate-lobbyinghttps://www.bloomberg.com/news/articles/2025-07-03/eu-fight-against-trump-s-tariffs-is-blunted-by-corporate-lobbyingThu, 03 Jul 2025 11:08:45 GMTThe Mercedes factory in Tuscaloosa, Alabama.